AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 2689-39-6 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 2689-39-6
Also known as: 2689-39-6, 4-(2-fluoro-4-nitro-phenyl)-morpholine, Morpholine, 4-(2-fluoro-4-nitrophenyl)-, 3-fluoro-4-morpholinonitrobenzene, Mfcd03138381, Cambridge id 6614516
Molecular Formula
C10H11FN2O3
Molecular Weight
226.20  g/mol
InChI Key
ZEQCFSSBZPZEFJ-UHFFFAOYSA-N
FDA UNII
36R3KP66K8

1 2D Structure

CAS 2689-39-6

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-(2-fluoro-4-nitrophenyl)morpholine
2.1.2 InChI
InChI=1S/C10H11FN2O3/c11-9-7-8(13(14)15)1-2-10(9)12-3-5-16-6-4-12/h1-2,7H,3-6H2
2.1.3 InChI Key
ZEQCFSSBZPZEFJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1COCCN1C2=C(C=C(C=C2)[N+](=O)[O-])F
2.2 Other Identifiers
2.2.1 UNII
36R3KP66K8
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 2689-39-6

2. 4-(2-fluoro-4-nitro-phenyl)-morpholine

3. Morpholine, 4-(2-fluoro-4-nitrophenyl)-

4. 3-fluoro-4-morpholinonitrobenzene

5. Mfcd03138381

6. Cambridge Id 6614516

7. Schembl210786

8. 3fluoro-4-morpholinonitrobenzene

9. Dtxsid60387723

10. Zeqcfssbzpzefj-uhfffaoysa-n

11. 36r3kp66k8

12. 3-fluoro-4-morpholinyl Nitrobenzene

13. 3-fluoro-4-morpholinyl-nitrobenzene

14. Stk351957

15. 1-fluoro-2-morpholino-5-nitrobenzene

16. 1-morpholino-2-fluoro-4-nitrobenzene

17. Akos005168040

18. Akos015922545

19. N-(2-fluoro-4-nitrophenyl)morpholine

20. Am86816

21. Sy005339

22. A818663

23. Sr-01000238859

24. Sr-01000238859-1

2.4 Create Date
2005-07-29
3 Chemical and Physical Properties
Molecular Weight 226.20 g/mol
Molecular Formula C10H11FN2O3
XLogP31.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count5
Rotatable Bond Count1
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area58.3
Heavy Atom Count16
Formal Charge0
Complexity253
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
168828-82-8
Linezolid
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001....
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001. It came from a subsidiary company of China National Pharmaceutical Industry Company affiliated to China National Pharmaceutical Group (CNPIC). BJ Zhongshuo runs a medicine R&D centre in Beijing Economic-Technological Development Area with over 20 experienced specialists and a batch of advanced equipment for experiment and detection. The centre deals with the R&D for innovated drugs and Generic drugs as well as the optimization and improvement on exiting products. The R&D centre is now able to deal with 10-15 new products per year.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
174649-09-3
Linezolid
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001....
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001. It came from a subsidiary company of China National Pharmaceutical Industry Company affiliated to China National Pharmaceutical Group (CNPIC). BJ Zhongshuo runs a medicine R&D centre in Beijing Economic-Technological Development Area with over 20 experienced specialists and a batch of advanced equipment for experiment and detection. The centre deals with the R&D for innovated drugs and Generic drugs as well as the optimization and improvement on exiting products. The R&D centre is now able to deal with 10-15 new products per year.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY